Key terms

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest MDT news

Yesterday 8:14am ET Piper says competitive process could materialize for ShockWave Yesterday 8:01am ET Medtronic announces FDA approval for Evolut FX+ TAVR Mar 26 4:47am ET Wells Fargo Releases a Buy Rating on Medtronic (MDT) Mar 22 6:42am ET Analysts Offer Insights on Healthcare Companies: Mediwound (MDWD), Medtronic (MDT) and Eledon Pharmaceuticals (ELDN) Mar 22 6:30am ET Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Medtronic (MDT) and Mediwound (MDWD) Mar 21 3:00pm ET Medtronic moves for patent infringement litigation with Axonics to resume Mar 14 6:28am ET Medtronic (MDT) Gets a Buy from Bernstein Mar 13 5:50am ET Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Medtronic (MDT) and Caribou Biosciences (CRBU) Mar 12 5:15am ET Buy Rating for Medtronic Amid FDA Clearances and Positive Market Outlook Mar 07 4:22pm ET Medtronic authorizes an incremental $5B for share repurchases Mar 07 12:33pm ET Medtronic recalls over 45,000 catheter tubing for catheter disconnection Mar 07 9:40am ET Unusually active option classes on open March 7th Mar 05 9:31pm ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Dexcom (DXCM), Orthofix (OFIX) and Medtronic (MDT) Feb 29 9:02am ET Medtronic files ITC action against Axonics Feb 29 8:16am ET Stifel Nicolaus Remains a Buy on Medtronic (MDT) Feb 29 6:30am ET Medtronic (MDT) Gets a Buy from Wells Fargo Feb 26 8:19am ET Orchestra BioMed presents new data on long-term effect of AVIM therapy Feb 23 10:37am ET Medtronic participates in a conference call with JPMorgan Feb 22 5:12am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Medtronic (MDT), Icon (ICLR) and Crispr Therapeutics AG (CRSP) Feb 22 12:51am ET Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Owens & Minor (OMI) and Warby Parker (WRBY) Feb 21 9:40am ET Medtronic price target raised to $90 from $87 at Truist Feb 21 8:00am ET Analysts Conflicted on These Healthcare Names: Cooper Co (COO), Medtronic (MDT) and Globus Medical (GMED) Feb 21 7:42am ET Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Medtronic (MDT) and Astria Therapeutics (ATXS) Feb 21 7:20am ET Analysts Conflicted on These Healthcare Names: NeoGenomics (NEO), Axsome Therapeutics (AXSM) and Medtronic (MDT) Feb 21 7:14am ET Medtronic price target raised to $75 from $72 at UBS Feb 21 6:51am ET Medtronic price target raised to $98 from $95 at Mizuho Feb 21 6:42am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (MDT), Teladoc (TDOC) and NeoGenomics (NEO) Feb 21 5:31am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Medtronic (MDT), Globus Medical (GMED) and Zai Lab (ZLAB) Feb 21 5:16am ET Medtronic’s Strong Financials and Strategic Focus Justify Buy Rating Feb 20 3:45pm ET Medtronic Buy Rating Affirmed with Increased Price Target Amid Strong Fiscal Performance and Strategic Focus Feb 20 3:15pm ET Maintaining Hold on Medtronic Amid Mixed Financial Signals and Strategic Shifts

No recent press releases are available for MDT

MDT Financials

1-year income & revenue

Key terms

MDT Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

MDT Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms